SAD/MAD study with PTC844
Phase 1
Active, not recruiting
- Conditions
- Auto immune disordersMedDRA version: 20.0Level: PTClassification code: 10061664Term: Autoimmune disorder Class: 100000004870Therapeutic area: Not possible to specify
- Registration Number
- CTIS2022-501986-38-00
- Lead Sponsor
- PTC Therapeutics Inc.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- All
- Target Recruitment
- 64
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method